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Promoting consistent HIV testing is critical among young, Black Men Who Have Sex With
Men (MSM) and transgender women who are overrepresented among new HIV cases in the
United States. New HIV test options are available, including mobile unit testing, one-minute
testing, at home or self-testing and couples HIV testing and counseling (CHTC). In the con-
text of these newer options, the objective of this study was to explore whether and how pref-
erences for specific characteristics of the tests acted as barriers to and/or facilitators of
testing in general and consistent testing specifically among young Black MSM and transgen-
der women aged 16 to 29.
Methods
We conducted 30 qualitative, semi-structured, in-depth interviews with young, Black, gay,
bisexual or MSM and transgender women in the New York City metropolitan area to identify
preferences for specific HIV tests and aspects of HIV testing options. Participants were pri-
marily recruited from online and mobile sites, followed by community-based, face-to-face
recruitment strategies to specifically reach younger participants. Thematic coding was uti-
lized to analyze the qualitative data based on a grounded theoretical approach.
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Results
We identified how past experiences, perceived test characteristics (e.g., accuracy, cost,
etc.) and beliefs about the “fit” between the individual, and the test relate to preferred testing
methods and consistent testing. Three major themes emerged as important to preferences
for HIV testing methods: the perceived accuracy of the test method, venue characteristics,
and lack of knowledge or experience with the newer testing options, including self-testing
and CHTC.
Conclusions
These findings suggest that increasing awareness of and access to newer HIV testing
options (e.g., free or reduced price on home or self-tests or CHTC available at all testing
venues) is critical if these new options are to facilitate increased levels of consistent testing
among young, Black MSM and transgender women. Addressing perceptions of test accu-
racy and supporting front line staff in creating welcoming and safe testing environments may
be key intervention targets. Connecting young Black MSM and transgender women to the
best test option, given preferences for specific characteristics, may support more and more
consistent HIV testing.
Background
New HIV infections among gay, bisexual and other men who have sex with men (MSM) ages
13 to 24 increased by 133% between 2001 and 2011 in the United States (US) (Johnson et al.,
2014) [1]. HIV prevalence and incidence are disproportionately high among young, Black
MSM and transgender women [2–7]. Recent research has observed a 5.9% annual HIV inci-
dence among young, Black MSM and transgender women aged 18 to 30 in six major urban
areas in the US [4]. New York City (NYC) has the largest number of newly diagnosed HIV
infections among MSM in the US [8]. Between 2001 and 2010 in NYC, new HIV diagnoses
increased among young MSM, with about half of all new cases among young, Black MSM [9].
Recent NYC surveillance data have revealed declines in new infections among MSM, but they
have not been statistically significant; in the first half of 2013 MSM made up 60% of all new
infections in NYC [10]. Further, while studies on Black transgender women have been limited,
recent epidemiologic data has shown that approximately 90% of newly HIV diagnosed trans-
gender women in NYC were among young, Black and Latina transgender women [11].
HIV testing is the entrance point to a range of HIV prevention and treatment options, such
as pre-exposure prophylaxis (PrEP) and ART (antiretroviral therapy) treatment, and is there-
fore a critical public health tool to help contain the HIV epidemic in the US [12–20]. It is cru-
cial that individuals learn of HIV infection as immediately as possible, as those who are
unaware of their HIV infection are more likely to transmit HIV to others due to higher viral
loads and higher prevalence of sexual HIV transmission risk behaviors [2, 8, 21–22]. Testing
offers individuals who engage in high risk sex and receive a negative test result the opportunity
to consider or adopt PrEP, a highly effective, biomedical HIV prevention method, learn about
PEP and/or work towards other risk reduction strategies [12–13, 23–25]. For these reasons,
the Centers for Disease Control and Prevention (CDC) has recommended that MSM and
transgender women who engage in certain risk behaviors test consistently or every 3–6 months
[8, 20, 25–26].
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Young Black MSM and transgender women are more likely to be unaware of their HIV
infection [8, 27–29]. In the 2014 National Health Behavior Survey (NHBS), 25.0% of Black
MSM (aged 18–24) and 23.0% (aged 25–29) had not tested in the prior 12 months; [8] fur-
ther, HIV testing is less frequent among undiagnosed HIV-infected Black MSM compared
to HIV-uninfected Black men [16]. The Brothers Study (HPTN [HIV Prevention Trials Net-
work] 061) found that almost a quarter of the 1,301 Black MSM with no prior HIV diagnosis
had not tested in the past year and MSM who had not tested recently were four times more
likely to have an undiagnosed HIV infection compared to those who had tested recently
[22]. Thus, consistent testing among this population subgroup is a critical public health
goal.
Barriers to HIV testing among Black MSM and transgender women include fear, stigma,
disclosure of sexual/gender identity, lack of anonymity, concerns about confidentiality, dis-
comfort talking to a counselor and concerns about the accuracy of rapid tests [30–34]. Facilita-
tors of testing include visits to health providers, perceived risk (a partner has HIV), sexually
transmitted infections (STIs), experiencing STI or acute HIV infection symptoms, condom
slips, being told by a partner to get tested, and social support [35–36]. One of the few studies
focused exclusively on young Black MSM found that the factors most strongly associated with
a lifetime history of HIV testing were knowing a comfortable place to test and social support
to discuss HIV and sexuality issues [37]. Peer social support has been associated with recent
HIV testing among young Black gay, bisexual, and other men who have sex with men, as has
social support in community samples of young Black MSM and transgender women [38–41].
There is limited research on what predicts consistent HIV testing among young Black MSM
and transgender women in an era of increased test options.
The emergence in recent years of several new testing methods and technologies have
increased HIV testing options, which may contribute to the goal of increasing consistent test-
ing among higher risk groups. These newer methods address some of the established barriers
to HIV testing described above. For example, home-based or self-testing uses a 20-minute,
oral fluid-based technology and allows individuals to operate the test and receive results pri-
vately and at their convenience, alleviating the burden of having to access traditional testing
venues or a health care provider, which may elicit stigma and confidentiality concerns [30, 42–
44]. In addition, couples HIV testing and counseling (CHTC) applies traditional rapid testing
methods in the context of a counselor-delivered session with two or more individuals who
consider themselves to be a couple or have sex together and seek testing services together. This
approach is delivered by trained test counselors and involves individuals receiving test results
together, supporting each other in the context of the results received and planning prospec-
tively for risk reduction via discussion of sexual agreements [45]. In addition to these new
operator (self), venue (home) and counseling (couple) options, traditional HIV testing with a
counselor at a fixed site or on a mobile unit is still widely available, typically using either the
20-minute oral fluid- or finger stick/blood-based rapid test. Finally, the one-minute HIV test
uses a finger stick blood specimen and offers results in one minute.
In the context of these newer options and the need for consistent HIV testing among high
risk MSM, we explored whether and how preferences for specific characteristics of the tests
acted as barriers to and/or facilitators of testing in general and consistent testing specifically
among young Black MSM and transgender women aged 16 to 29. We also evaluated percep-
tions of the “fit” between available methods and their characteristics and participants’ past and
future testing needs. The findings presented here result from a formative research phase of a
larger study designed to inform the development of a communication technology-based inter-
vention to increase consistent HIV testing among this age group.
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Methods
Recruitment and eligibility
Participants were recruited between February and May 2014 through online and mobile appli-
cations (apps) used by young, Black MSM and transgender women in the New York City met-
ropolitan area (e.g., Craigslist, Black Gay Chat [BGC], Facebook, etc.) and the homepage of a
local organization for gay men of African descent. Face-to-face recruitment was used to reach
the participants aged 16 to 19. Recruitment language and ads explicitly included transgender
women. Using these methods, 396 individuals (MSM, N = 378; transgender women, N = 18)
completed the online screener and 78 (20%) were eligible. Face-to-face recruitment occurred
at two events (a kiki ball or mini-House Ball, and at an outdoor venue, “The Piers”, in lower
Manhattan) where young, Black MSM and transgender women often gather; 18 contacts were
collected and 14 were eligible (78%).
To be eligible for the study participants had to: (1) report being male at birth; (2) self-
identify as Black, African American, Caribbean Black, African Black or multiethnic Black;
(3) be able to read and respond in English; (4) be between 16–29 years of age; (5) not be
known to be HIV-infected; (6) report insertive or receptive anal intercourse with a man or
transgender woman in the last 12 months; (7) reside in the NYC metropolitan area; and (8)
provide informed consent or assent for the study. Participants who were enrolled in any
other HIV research study involving HIV testing or who had been a participant in an HIV
vaccine trial were not eligible. Sexual identity was not a criterion, as self-reported behavior
was used to establish eligibility. To provide appropriate contrasts, we attempted to interview
participants who had and had not tested for HIV at least once in the last six months.
The recruitment methods resulted in a sample of 30 participants, which was the target sam-
ple for the study and where we reached saturation with regard to the themes emerging
around preferences for, barriers to and facilitators of HIV testing in the context of newer
options.
Study procedures
Participants who screened as preliminarily eligible were contacted by telephone to confirm
eligibility and set up a study visit appointment. All participants provided written informed
consent or assent and the study was reviewed and approved by the Institutional Review
Boards (IRBs) of all participating institutions (New York Blood Center, Binghamton Univer-
sity, and Public Health Solutions). Eligible participants under the age of 18 years were con-
sidered mature minors by the IRBs and thus provided written informed assent. After
providing information about the study and prior to obtaining assent, the minor participant
was introduced to and met with the minor advocate. The advocate was a staff member who
was not involved in the assent or this study’s procedures. All information provided by the
participant during the meeting with the advocate was confidential and not shared with any
other staff members. At the end of the study visit, the participant was provided the opportu-
nity to meet with the advocate again and given the advocate’s contact information for any
future questions. Eligible participants completed a 60-minute, qualitative, semi-structured,
in-depth interview and a brief web-based survey on demographics, health characteristics,
and sexual behavior. Participants who completed the study visit received $30 compensation
for their time, along with a two-way Metrocard for travel. Interviews were conducted by
trained and experienced interviewers in a private room and were audio-recorded and profes-
sionally transcribed. All interviews were checked for accuracy by the primary qualitative
study co-investigators (VF and LW).
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Interview guide
The in-depth interview was semi-structured, employing a guide that explored a variety of
issues including: personal background; experience of and connection to communities;
thoughts and feelings about HIV testing and most recent testing experience; experiences with
and perceived facilitators of and barriers to newer testing methods (e.g., couples testing, also
known as “Testing Together”), venues (e.g., mobile units), and operators (e.g., self-testing);
and use of and thoughts about web- and smart phone app-based technologies for health and
testing purposes. The interview guide was based on a conceptual model that identified factors
at four levels, the test level, the individual level, the situation level, and the socio-contextual
level. At the test level, we asked questions designed to elicit accounts of the influence of test
characteristics, such as availability, cost, fluid used/specimen collected, test operator, familiar-
ity, complexity, time for results, and privacy/confidentiality on testing and test preference. At
the individual level, we explored the influence of fear, anxiety, stigma, past experiences and
“type” of tester, [46] as well as medical mistrust. In terms of the situation and social context,
we assessed how cues to action, situational access, counseling type and quality, peer norms,
and general social context related to testing. In this report, we focus on data related to whether
and how specific test characteristics connect to preferences for, barriers to and facilitators of
testing in general and consistent testing specifically. During the interview, interviewers
described the two commercial self-tests currently available, the OraQuick In-Home HIV
Test1 (OraSure Technologies; Bethlehem, Pennsylvania), approved in July 2012, and the
Home Access1 HIV-1 Test System (Home Access Health Corporation; Hoffman Estates, Illi-
nois), noting the cost of, process used, and specimen collected with each method.
Analytic methods
Using a grounded theoretical approach, we applied both contextualizing and categorizing
strategies to code and analyze the in-depth interview data [47–48]. Immediately after each
interview, the interviewer developed a summary document that described the participant’s life
history, experiences with HIV testing, dominant themes of the interview and selected social
characteristics. All summaries and transcripts were read by the analytic team and the lead ana-
lysts (the first two authors). A list of analytic areas represented in the data were composed and
coded. The lead analysts re-read all transcripts and conducted preliminary coding of the text,
based on interview topics and themes that were identified through the reading of the tran-
scripts. The lead analysts coded the first five interviews and inter-rater reliability was evaluated;
although the reliability was acceptable, the analysts discussed the inconsistent codes and coded
another five interviews. These were compared and inter-rater reliability was found to be
acceptable; the remaining 20 interviews were coded by the second author in QSR Internation-
al’s NVivo 10 qualitative software (QSR International Pty Ltd. Version 9, 2010). Once the data
were coded, queries were run on the following codes: “HIV test and person type”, “HIV test
availability, characteristics and past testing”, “HIV testing preferred method”, “HIV testing
accuracy”, “HIV testing barriers-past”, “HIV testing facilitators—past”, as well as text coded
according to specific characteristics of testing, such as “fluid type”, “operator”, and “venue”.
These portions of text were compiled, read, and analyzed by the lead author. Finally, all tran-
scripts were re-read in full to confirm that no reported quote was overly de-contextualized
from the larger narrative. We paid attention to data that did not confirm emerging or domi-
nant themes, noting these in the results. In addition, we assessed whether the dominant themes
were evenly represented among the four participants who self-identified as transgender and/or
described being gender fluid and whether they varied by recent (past six months) HIV testing
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history. All participant quotes are identified by initials (not actual) and selected sociodemo-
graphic characteristics to protect privacy.
Results
Sample
The mean age of the sample was 23.7 (SD = 3.4), with one 17-year old participant and eight
participants who were between 18 and 21 years of age; 21 participants were aged 22 to 29.
Forty percent reported residing in the Bronx, 30% in Brooklyn, 27% in Manhattan, and 3% in
Queens. The majority (87%) self-identified as African-American, with 23% identifying as
Caribbean or West Indian or 20% as Afro-Latino. Ninety-three percent of participants self-
identified as male, with two participants identifying on the computer-based survey as trans-
gender male-to-female. During the interviews, however, another two participants revealed that
they self-identified as gender fluid and sometimes identified as male-to-female transgender,
sometimes as female and sometimes as male. Table 1 provides additional sociodemographic,
perceived HIV risk and past HIV testing characteristics of the sample.
Established barriers to and facilitators of HIV testing
We confirmed results of previous research that several factors continue to act as barriers to
and facilitators of HIV testing in this population. These included: knowledge of and access to
HIV testing sites and test methods, fear of a reactive HIV test result, HIV stigma, and concerns
around confidentiality and privacy. In terms of access to newer testing methods, the majority
of participants were unaware of the CHTC option (which was not widely available at the time
of the interviews), although they were open to and enthusiastic about CHTC. One participant
noted its usefulness in planning for safety with a future partner, saying “I would do the Testing
Together to get to know the person and where they stand.” (NO5; 24, African-American, male,
Bronx, not tested P6M) Another participant noted that if the new methods were widely dis-
seminated, they would be used, stating “I think maybe I could be—not really comfortable with
it, but I feel like if it was much more available, then I would possibly take advantage of it.”
(ST1; 21, African-American, male, Bronx, tested P6M) A transgender participant said in
response to being told of the various testing options that there were “a lot more options than
what I am aware. I’m excited. I’m excited.” (WX5; 20, African-American, gender fluid, Brook-
lyn, not tested P6M)
Some participants noted that access to existing testing methods was still a problem, particu-
larly in the Bronx, with too few fixed testing sites available. One participant said, “New York
City has facilities specifically for that spread around the borough, but there’s only like two a
borough.” (DE4; 20, African-American, male, Manhattan, not tested P6M) Related to access
to the self-test, the cost of the test emerged as a barrier, consistent with preliminary reports in
the literature and our analysis of these data (Frye et al., 2015). The majority of participants
expressed anxiety or nervousness when asked their “first thoughts” on HIV testing, reinforcing
that the testing experience continues to be fraught with anxiety for most young, Black MSM
and transgender women. One participant said, “I’m high anxiety so, you know, that will defi-
nitely get my anxiety going and stuff, just yes, worrisome.” (CD3; 28, Afro-Latino, male,
Bronx, not tested P6M) Another participant simply said “fear,” whereas another stated “sick-
ness, depression, condoms, wrap it up, and depression.” (NO5; 24, African-American, male,
Bronx, not tested P6M) One stated “It’s draining.” (XY6; 22, African-American, male, Bronx,
tested P6M) The role of stigma associated with testing also emerged for several participants
when asked about their first thoughts on testing; one participant said “I guess shame. Even
though I work with the disease itself, I’m not scared of it. I respect it. But it still holds a stigma.
YBMSM and HIV testing
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Table 1. Sociodemographic, health, HIV risk perception, and HIV testing characteristics of sample (N = 30‡).
Factor N Percent
Age (mean; SD) 23.7 3.4
Race/ethnicity
African-American 26 87%















Staten Island 0 0%
US-born (N = 29) 27 89%
Education (N = 28)
High school degree or GED 7 23%
Technical School 2 7%
Some college 15 50%
College degree or more 4 13%
Income greater than $20,000 per year (N = 28) 12 40%
Provision of rent, food, utilities and living expenses
Self 21 69%
Parents/other relatives 13 43%
Other 2 7%
Income insecurity (very or fairly often) (N = 28) 9 30%
Employment (N = 27)
Full-time work 10 33%
Part-time work 6 20%
Not working 10 33%
Working off the books 1 3%
Health insurance (N = 28) 25 82%
Medical care receipt (usual) (N = 28)
private MD 17 56%
emergency department 7 23%
community clinic 4 13%
Perceived likelihood of getting HIV (N = 28)
Extremely or very unlikely 13 43%
Unlikely 11 36%
Likely 4 13%
Extremely or very likely 0 0%
Worried about getting HIV (N = 28) 17 56%
(Continued)
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You don’t necessarily want that stigma attached. . . . So it’s not a nice feeling.” (RS9; 29, Afri-
can-American, male, Brooklyn, tested P6M) Finally, as in previous research, issues related to
confidentiality emerged, with some participants perceiving fixed site waiting rooms and
mobile units to be antithetical to privacy, for example.
Emergent barriers to and facilitators of HIV testing
In this section, we present novel results describing how preferences for selected characteristics
may constitute barriers to and facilitators of testing and explore how some of these preferences
interacted with each other. We describe preferences that emerged from the data most strongly,
organized by test characteristics (e.g., specimen type required, reported accuracy, etc.), indi-
vidual/personal characteristics (e.g., perceived accuracy, anxiety, etc.), and the situational or
contextual characteristics (e.g., venue, location, etc.).
Test and individual characteristics
Related to the test characteristics, factors such as type of specimen collected, reported accuracy,
familiarity with the actual testing process and speed of the test results emerged as important to
test preferences. Several participants expressed a strong preference for blood-based tests and
venipuncture due to greater accuracy of these tests and fewer false negative test results, as com-
pared to oral fluid-based tests. Some participants believed that blood-based tests, venipuncture
with a western blot test in particular, were more sensitive, resulting in shorter window periods
and greater confidence in blood-based tests. For example, one participant said:
“But like I said, with me it’s not so much the convenience and stuff like that. Sometimes I
just don’t trust the results for somebody to swab your mouth and a little thing of blood to
detect. I mean—I know that this has been tested for ages before we even got it, so I know
that there is, you know, they know what they’re doing, but it’s just me up in my head. . . . I
prefer to get a needle in my arm and I’ll see you in a week to ten days.”
(BC2; 29, African-American, male, Bronx, not tested P6M)
Table 1. (Continued)
Factor N Percent
HIV tested, lifetime 29 96%
HIV tested, past six months (N = 28) 19 63%
Venue most recent HIV test (n = 27)
Community health/free clinic or CBO 14 46%
Private medical doctor 7 23%
Mobile testing unit 2 7%
Emergency department, research study or other 4 13%
Specimen type most recent HIV test (N = 27)
Whole blood draw 11 36%
Finger prick 6 20%
Oral fluid 10 33%
 totals to greater than 30, as multiple answer choices were accepted
‡ Ns for each factor are listed when one or more participant declined to answer
https://doi.org/10.1371/journal.pone.0192936.t001
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Expressing greater confidence in blood-based rapid tests, another participant said, “For me,
it’s more accurate. HIV lives in the blood. . . . Check the blood.” (DE4; 20, African-American,
male, Manhattan, not tested P6M) Another said: “I really don’t trust it [the oral fluid], so every
time I go in there and get it I think I don’t trust it.” (BC3; 19, African-American/Afro-Latino,
male, Brooklyn, tested P6M) Another asked, “Isn’t the blood test more accurate? I really—I
want to know. I want to be 100% sure. Every time I get tested, I want to be 100% sure that it’s
correct—there’s no ands, ifs, or buts about it.” (FG6; 19, African-American, male, Brooklyn,
tested P6M) One participant worried that the preference for blood-based tests may prevent
some people from getting rapid HIV tests. This participant said: “I believe the only obstacle
would be the fact of their preference of venipuncture over the rapid testing. I hope that doesn’t
stop them from getting it. I hope they still think, you know, this is good enough for right now.
Even though my preference is venipuncture, I hope they feel like I should do this right now
just to at least know my status some way.” (DE4; 20, African-American, male, Manhattan, not
tested P6M) This participant recognized the potential for the perception of significantly
reduced accuracy of rapid HIV tests, oral fluid-based in particular, to act as a barrier to consis-
tent or needed testing.
Situational or contextual characteristics: Counselor and venue
In terms of situational or contextual characteristics, factors such as relationship status, past
testing patterns, prior negative experiences with testing (e.g., specific counselors or providers
and mobile units especially), counselor skill and compassion, and venue culture (e.g., courte-
ousness, confidentiality, etc.) emerged as important to preferences for specific testing methods
or test characteristics. Of special importance for several participants was the relationship they
developed with their counselors and/or perceived attitudes of counselors towards the clients.
One participant who sought testing every four months noted, “I mean it’s one of those—
they’re there to do their jobs. So it’s not like they’re enthusiastic or they have enthusiasm to do
the test for you. So it’s like a regular job for them.” (GH7; 25, African-American, male, Bronx,
tested P6M) Counselor skill at taking a sample emerged as well in terms of wanting to return
to either the venue and/or use the specimen collection method again. The same participant
described an adverse oral fluid specimen collection experience where “the lady doing it—
because they’re supposed to do it for you. So when they do it, it looks like they’re fighting with
your mouth. . .and I’m like, ‘Is this really supposed to happen?’” (GH7; 25, African-American,
male, Bronx, tested P6M) Another participant said that the attitude of the clinic workers to
their roles was important noting:
“I went to one in [NYC neighborhood] and I really didn’t like it. [Why not?] I don’t know.
The whole environment, the people that were there, and the workers, they weren’t—they
sounded like they were pissed the whole day, so I was like, ‘This is not the place for me.’. . .
The people [waiting to be seen], whatever they were doing, they looked upset as well. And
they were on the phones arguing and stuff like that, so it was. . .”
(HI8; 26, African-American, male, Manhattan, tested P6M)
Other participants noted that selected testing venues, specifically mobile testing units, were
not conducive to confidentiality, comfort, or confidence. For example, one participant who
said that they would not seek a test on a mobile unit or van said:
“I don’t think I feel comfortable in vans. I just feel like vans are for delivering things that
you need. I don’t think I should be getting my results while you’re parking or while you’re
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parked in the yellow line. It just doesn’t feel comfortable for me. It doesn’t feel like it’s real,
honestly.”
(PQ7; 23, African-American, male, Manhattan, tested P6M)
The impermanence and mobility of the vans disconcerted some participants; when asked
what disturbed them about the van one participant replied “Just the idea that they could just
lock the doors and run off with you.” (FG6; 19, African-American, male, Brooklyn, tested
P6M). Another noted, “I walk by them every single time. It’s—I don’t trust it.” (BC3; 19, Afri-
can-American/Afro-Latino, male, Brooklyn, tested P6M) In contrast, a few participants appre-
ciated the convenience and easy access that mobile testing units provide. One participant who
was never tested said they would feel “less exposed” when testing on a van, suggesting that they
did not want to be seen going into a fixed testing site (AB9; 20, African-American, male,
Queens, never tested). Another participant noted that the vans often allowed testing with
friends or had a positive energy (CD4; 17, Caribbean/West Indian, male, Bronx, not tested
P6M).
Testing method preferences over time
In addition to identifying characteristics of the tests and situation that drive preferences for
testing methods, we asked participants about hypothetical preferences for various methods
and test characteristics at different stages of their lives. Participants believed that they may
benefit from a range of test options, noting that some methods would be good for them at dif-
ferent times in their lives. For example, a few participants felt that their current living situa-
tions would preclude their use of a self-test; for example, one participant noted “And the at-
home test, my parents know that I’m sexually active and I identify as a homosexual, but I don’t
think I would want to do it while they’re there. . .I don’t want them questioning anything like,
“What are you doing?” I don’t want to have to go through those conversations.” (FG6; 19, Afri-
can-American, male, Brooklyn, tested P6M)
In contrast, another participant imagined that they would combine self-testing at home
(using oral fluids) with venipuncture at their health care provider’s office at a different stage in
their life:
“Okay, the oral tests I would probably do every once in a while, at home, but, you know, to
get the blood draw, I would probably do it every time I had my doctor’s visit. That would be
the only times that I would change it up.”
(CD3; 28, Afro-Latino, male, Bronx, not tested P6M)
Another resident of the Bronx noted that having access to the self-test would allow them to
test at home and would save them time during life stages characterized by time pressure and a
hectic schedule (DE4; 20, African-American, male, Manhattan, not tested P6M).
Most participants indicated that CHTC (with a sex partner) would be of interest at time of
life when they were partnered or “settled down,” although some said that the complexity of
and commitment inherent in the method, specifically testing with a sex partner and discussion
of sexual agreements, etc., would be a barrier. Further, the issue of trust while testing with a
sex partner or friend emerged as a strong barrier to using this method at any life stage for sev-
eral participants. With that said, a few participants reported that CHTC was an ideal way to
test, particularly in the event of a reactive test result; one participant said this of having a friend
or partner present:
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“You have people to fall back on. You always want somebody to talk to after, you know, on
the train ride home or something. People could calm you down. They could tell you things,
they could tell you experiences, share stories.”
(QR8; 22, African-American, male, Brooklyn, tested P6M)
We explored with participants whether the existence of one of the options described,
including the self-test, CHTC and the 1-minute test, would have increased the chance that
participants would have tested at a time in their lives when they “thought they should have
tested, but had not.” One participant noted that the 1-minute test would have made it more
likely that they would have tested; another participant said they would have used the self-test
to keep things private when they were younger and in need of testing. Similarly, another said
that if the home test had been available when he was younger, he would have tested sooner.
Another participant indicated that in the past if a testing option had been nearby, quick and
convenient and he’d had a higher risk sexual experience, he would have been more likely to
test at a time when a test was needed but not accessed. In terms of options that are missing
from the current testing environment and that would potentially increase consistent testing,
one participant lamented that results could still not be delivered by phone, which would
reduce anxiety associated with receiving results. One participant noted that a more sensitive
test would make them more likely to test more frequently, saying “if they said maybe it can
be detected, I guess, in like a shorter time frame, then, I guess, that would maybe make me go
every two or three months, if I was like really, really active.” (IJ9; 21, African-American,
male, Manhattan, tested P6M) Most participants could not imagine another testing option
that would significantly increase their chances of testing or testing consistently. One partici-
pant said:
“I’m not really sure that anything’s missing, because I think they’re all kind of convenient in
a way. So, it’s like there’s not really a reason why you can’t go get yourself tested. They’re
kind of available everywhere you go now at this point. So, it’s like there’s no excuse to not
get tested.”
(CD4; 17, Caribbean/West Indian, male, Bronx, not tested P6M)
Perceived person-method fit
Finally, when asked if “certain tests were a better fit for certain people”, most responses
focused on use of the home or self-test. Numerous participants indicated that the self-test is
useful to those who could afford the higher price, noting that they would gain the benefit and
flexibility inherent in the test. A few participants stated with concern that self-testing may be
preferred by a “certain type of person” (one participant described them as “secret closet peo-
ple” (MN4; 29, African-American, transgender, Brooklyn, tested P6M), one who does not
intend to disclose a positive result. They speculated that the type of person who uses a self-
test may be afraid to be seen attending a clinic or asking for a test from their doctors. In
terms of the preference for blood-based or venipuncture, one participant articulated what
was described by several other participants: that the person who strongly prefers venipunc-
ture is the person who “worries a lot, that needs to know and, you know, that wants to do it
the perfect way the first time, that kind of a person.” (CD3; 28, Afro-Latino, male, Bronx, not
tested P6M)
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Discussion
The numerous HIV testing options that are now available provide more choices to individuals
at higher risk for HIV infection, for whom consistent HIV testing is recommended. However,
there is limited understanding of how newer testing options are perceived, including what
aspects of the new options are preferred, and how these preferences could increase the likeli-
hood of testing and/or consistent testing [49–50]. In this study, we explored with young, Black
MSM and transgender women their perceptions of various aspects of HIV testing methods in
an effort to uncover whether selected test or testing experience characteristics, specifically test
characteristics, individual preferences and situational or contextual factors, strongly drove
preferences for specific testing methods. Three major themes emerged as important to prefer-
ences for HIV testing methods: the perceived accuracy of the test method, venue characteris-
tics, and lack of knowledge or experience with the newer testing options, including self-testing
and CHTC. This last finding suggests that dissemination of these options has been limited in
this major metropolitan and high HIV prevalence area. There is a need for a concerted, city-
led effort to disseminate self-testing and CHTC in the New York City area, with the goal of sig-
nificantly increasing knowledge of and access to these newer text technologies.
A driver of preference for blood-based specimen collection was consistently described in
terms of the greater perceived accuracy of blood as opposed to oral fluid sample-based tests.
This preference was evident among both recent and not recent testers, suggesting that it acts as
a barrier to testing for some but not all potential testers. It is likely that, despite the young age
of the participants and thus relative lack of testing experience, the actual reduced sensitivity of
oral fluid tests has been communicated to them and may be acting as a barrier to testing ven-
ues or methods that rely on oral fluids [8, 51]. In addition to the scholarly literature that docu-
ments the reduced sensitivity of oral fluid, the fact that OraQuick use resulted in a spate of
false positives in the New York City area [52–53 may also be well-known among those people
who test frequently and test counselors. As one participant noted, it is likely that this knowl-
edge is acting as a barrier to testing or consistent testing, as it constitutes yet another source of
anxiety for those who are in need of testing [27–34]. Most participants described fear and anxi-
ety as the dominant emotional responses to the thought of HIV testing; that the test employed
might not provide definitive information on HIV status adds to this baseline anxiety, and may
cause some people to delay testing while searching for a blood-based option or postpone the
test indefinitely. Because this analysis is based on qualitative data it is not possible to character-
ize how strong a barrier this factor is in delayed testing, but it may be an overlooked or under-
emphasized barrier that is exerting a stronger than expected effect on deferred HIV testing in
the population subgroup.
Two related situational or contextual factors emerged as drivers of preference and desire to
return for future testing: counselor interpersonal skills and venue culture. Several participants
reported that they felt that HIV test counselors were only “doing a job” or “going through the
motions,” suggesting that the importance and gravity of the testing process was not appreci-
ated consistently by counselors and reflected in interactions with clients. This perception,
based on actual experiences, may inhibit future consistent testing. Although recent research
reported that the counseling component of voluntary counseling and testing (VCT) does
not prevent incident STIs, [54–55] it continues to be an important part of comprehensive HIV
prevention, as it allows clients to be evaluated for PrEP and other biomedical prevention
approaches, such as PEP. It is important to gain a better understanding of how members of
high-risk groups or populations, where medical mistrust is well-founded, [56–57] experience
HIV test and PrEP/PEP counseling given the results presented here on the importance of
counselor skills and venue culture.
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Two additional findings emerged that have implications for HIV prevention and social
services. First, the young people sampled here were able to imagine using a range of test
approaches at various points in their lives, based on where they were in their lives. Although
some participants noted that reluctance to test was unconnected to access and knowledge,
and rather reflected fear of HIV, several stated that had the self-test been available to them
when they were younger they would have used it. Similarly, the lack of easy access to all the
testing approaches was perceived as a barrier to testing for very young, emerging adults. This
strongly suggests that in addition to efforts to increase knowledge of and access to the full
range of testing approaches, the public school system should integrate information on all
testing approaches currently available as well as provide access to HIV testing in high schools
and provide HIV self-tests to students who seek them [58]. Second, the finding that partici-
pants thought that a particular “type” of person might prefer to use a self-test is somewhat
concerning. This suggests that that these tests could become stigmatized by association with
perceived higher-risk or “closeted” individuals who do not intend to disclose a positive sta-
tus. We noted that the self-test was identified by those who had not tested recently as an
attractive option that they would use in the future and/or would have used previously to test.
It is important that young people consider the self-test as one option among several that
allows optimal sexual health management rather than a tool to maintain the fear, shame, and
secrecy that some feel around HIV testing. With increased dissemination and distribution,
possibly via public high schools, the self-test has a greater chance of being seen as a positive
and accepted component of a consistent testing plan, capitalizing on the full range of avail-
able methods, that can flexibly meet different testing-related needs at various times of life or
situations.
Limitations
There are several limitations that deserve mention. First, despite an effort to focus on younger
people, we interviewed just one person younger than age 18 and thus our findings derive pri-
marily from a young adult population. Along these same lines, just four participants self-
identified as either transgender (male to female) or gender fluid. Given the significant hetero-
geneity within the transgender population, for example preferred gender identity, pre-opera-
tive or post-operative status, health care history, we cannot draw strong conclusions related
to the communities and subpopulations within the transgender population. In addition, we
recruited participants primarily using web-based approaches, supplemented by in-person
recruitment efforts to reach younger participants. Thus, the sample may over-represent indi-
viduals who gather on-line, as opposed to people who gather face-to-face at venues. This sam-
pling strategy was, however, designed to reach young MSM and transgender women who
would be likely to encounter our web-based testing intervention. Related to sampling, the
results cannot be generalized to the larger population of young, Black MSM and transgender
women; rather, these qualitative analyses are meant to generate novel findings around prefer-
ences for specific test characteristics in an era of increased testing options. Finally, most of
our sample had tested for HIV within the last six months and few had direct experience with
the testing options that we explored in the interviews. As CHTC and self-testing options are
scaled up and formally disseminated, it will be important to conduct ongoing research into
how these options are experienced by the groups at highest risk and most in need of testing
options. If added options continue to be perceived as options for other people or other times
of life, they will do little to increase the consistent testing that is required to trigger clinical
evaluation for PrEP.
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Conclusions
These findings suggest that increasing awareness of and access to newer HIV testing options
(e.g., free or reduced price on home tests or CHTC available at all testing venues), among
young, Black MSM and transgender women is necessary if these new options are to facilitate
increased levels of consistent testing in these at-risk populations. Effective dissemination of the
methods, leading to easy access and uptake, is critical to this goal [49]. Further, as different
methods of HIV testing may be preferred at different phases of life, the increased number of
options may collectively act to increase chances of consistent testing across the life course [59].
Further experimental research would be needed to conclude if programs that help individuals
develop tailored testing plans that take into account the full range of testing options and life
stage increase consistent testing. Finally, HIV screening program planners and school health
professionals should consider generating awareness and demand for the full range of test
options through social and other media awareness-raising campaigns and provide easy access
to all testing options [58].
Supporting information
S1 File. FINAL AAM in-depth interview guide.
(DOC)
Acknowledgments
The All About Me Study Team members include Beryl Koblin, Victoria Frye, Mary Ann Chias-
son, Sabina Hirshfield, Leo Wilton, Donald Hoover, Vijay Nandi, Debbie Lucy, DaShawn
Usher, Jermaine McCrossin, Geneva Ortiz, and Kiwan Stewart. Thank you to the participants
who agreed to take part in this research. The authors thank the All About Me Community
Consulting Group for their help and input into the design and implementation of the study.
Thank you to the outstanding Project Achieve staff who make this work possible.
Author Contributions
Conceptualization: Victoria Frye, Leo Wilton, Sabina Hirshfield, Mary Ann Chiasson, Beryl
Koblin.
Data curation: Victoria Frye, Leo Wilton, Jermaine McCrossin, Beryl Koblin.
Formal analysis: Victoria Frye, Leo Wilton.
Funding acquisition: Beryl Koblin.
Investigation: Victoria Frye, Leo Wilton, Sabina Hirshfield, Mary Ann Chiasson, Beryl
Koblin.
Methodology: Victoria Frye, Leo Wilton, Sabina Hirshfield, Mary Ann Chiasson, Jermaine
McCrossin, Beryl Koblin.
Project administration: Debbie Lucy, DaShawn Usher, Jermaine McCrossin, Emily Greene,
Beryl Koblin.
Resources: Beryl Koblin.
Supervision: Victoria Frye, Leo Wilton, Debbie Lucy, DaShawn Usher, Beryl Koblin.
Writing – original draft: Victoria Frye, Leo Wilton, Sabina Hirshfield, Mary Ann Chiasson,
Debbie Lucy, DaShawn Usher, Jermaine McCrossin, Emily Greene, Beryl Koblin.
YBMSM and HIV testing
PLOS ONE | https://doi.org/10.1371/journal.pone.0192936 February 20, 2018 14 / 18
Writing – review & editing: Victoria Frye, Leo Wilton, Sabina Hirshfield, Mary Ann Chias-
son, Debbie Lucy, DaShawn Usher, Jermaine McCrossin, Emily Greene, Beryl Koblin.
References
1. Johnson AS, Hall HI, Hu X, Lansky A, Holtgrave DR, Mermin J. Trends in diagnoses of HIV infection in
the United States, 2002–2011. JAMA. 2014; 312(4):432–434. https://doi.org/10.1001/jama.2014.8534
PMID: 25038362
2. Gray KM, Cohen SM, Hu X, Li J, Mermin J, Hall HI. Jurisdiction level differences in HIV diagnosis, reten-
tion in care, and viral suppression in the United States. J Acquir Immune Defic Syndr. 2014; 65(2):129–
132.
3. Hall HI, Song R, Tang T, An Q, Prejean J, Dietz P, et al. HIV trends in the United States: Diagnoses and
estimated incidence. JMIR Public Health Surveill. 2017; 3(1):38. https://doi.org/10.2196/publichealth.
7051 PMID: 28159730
4. Koblin BA, Mayer KH, Eshleman SH, Wang L, Mannheimer S, del Rio C, et al. Correlates of HIV acquis-
tion in a cohort of Black men who have sex with men in the United States: HIV prevention trials network
(HPTN) 061. PLoS One. 2013; 8(7):e70413. https://doi.org/10.1371/journal.pone.0070413 PMID:
23922989
5. Maulsby C, Millett G, Lindsey K, Kelley R, Johnson K, Montoya D, et al. HIV among Black men who
have sex with men (MSM) in the United States: A review of the literature. AIDS Behav. 2014; 18(1):10–
25. https://doi.org/10.1007/s10461-013-0476-2 PMID: 23620241
6. Mayer KH, Garofalo R, Makadon HJ. Promoting the successful development of sexual and gender
minority youths. Am J Public Health. 2014; 104(6):976–81. https://doi.org/10.2105/AJPH.2014.301876
PMID: 24825194
7. Prejean J, Song R, Hernandez A, Ziebell R, Green T, Walker F, et al. Estimated HIV incidence in the
United States, 2006–2009. PLOS ONE. 2011; 6(8):e17502. https://doi.org/10.1371/journal.pone.
0017502 PMID: 21826193
8. Centers for Disease Control and Prevention. HIV infection, risk, prevention, and testing behaviors
among men who have sex with men—national HIV behavioral surveillance, 20 U.S. cities, 2014. HIV
Surveillance Special Report. 2016;15:1–32. https://www.cdc.gov/hiv/pdf/library/reports/surveillance/
cdc-hiv-hssr-nhbs-msm-2014.pdf. Accessed 27 Feb 2017.
9. Centers for Disease Control and Prevention. HIV Surveillance Report, 2010; 2012, vol. 22: 1–79.
https://www.cdc.gov/hiv/pdf/statistics_surveillance_report_vol_22.pdf. Accessed 27 Feb 2017.
10. New York City Department of Health and Mental Hygiene. HIV Surveillance Annual Report, 2014. 2015.
https://www1.nyc.gov/assets/doh/downloads/pdf/dires/2014-hiv-surveillance-annual-report.pdf.
Accessed 27 Feb 2017.
11. New York City Department of Health and Mental Hygiene. HIV among people identified as transgender
in New York City, 2011–2015. 2016. https://www1.nyc.gov/assets/doh/downloads/pdf/dires/hiv-in-
transgender-persons.pdf. Accessed 27 Feb 2017.
12. Behler RL, Cornwell BT, Schneider JA. Patterns of social affiliations and healthcare engagement
among young, Black, men who have sex with men. AIDS Behav. 2017 Jan 21. https://doi.org/10.1007/
s10461-016-1668-3 [Epub ahead of print]. PMID: 28108879
13. Eaton LA, Matthews DD, Driffin DD, Bukowski L, Wilson PA Stall RD, et al. A multi-US city assessment
of awareness and uptake of pre-exposure prophylaxis (PrEP) for HIV prevention among Black men and
transgender women who have sex with men. Prev Sci. 2017 Jan 18. https://doi.org/10.1007/s11121-
017-0756-6 PMID: 28101813
14. Hoots BE, Finlayson T, Nerlander L, Paz-Bailey G, National HIV Behavioral Surveillance Group. Willing-
ness to take, use of, and indications for pre-exposure prophylaxis among men who have sex with men-
20 US cities, 2014. Clin Infect Dis. 2016; 63(5):672–7. https://doi.org/10.1093/cid/ciw367 PMID:
27282710
15. Finlayson TJ, Le B, Smith A, Bowles K, Cribbin M, Miles I, et al. HIV risk, prevention, and testing behav-
iors among men who have sex with men-National HIV Behavioral Surveillance System, 21 U.S. cities,
United States, 2008. MMWR Surveill Summ. 2011; 60(14):1–34. PMID: 22031280
16. Millett GA, Ding H, Marks G, Jeffries WL 4th, Bingham T, Lauby J, et al. Mistaken assumptions and
missed opportunities: correlates of undiagnoses HIV infection among Black and Latino men who have
sex with men. J Acquir Immune Defic Syndr. 2011; 58(1):64–71. https://doi.org/10.1097/QAI.
0b013e31822542ad PMID: 21654500
17. Mimiaga MJ, Closson EF, Battle S, Herbst JH, Denson D, Pitts N, et al. Reactions and receptivity to
framing HIV prevention message concepts about pre-exposure prophylaxis for Black and Latino men
YBMSM and HIV testing
PLOS ONE | https://doi.org/10.1371/journal.pone.0192936 February 20, 2018 15 / 18
who have sex with men in three urban US cities. AIDS Patient Care STDS. 2016; 30(10):484–489.
https://doi.org/10.1089/apc.2016.0123 PMID: 27749110
18. Morgan E, Oster AM, Townsell S, Peace D, Benbow N, Schneider JA. HIV-1 infection and transmission
networks of younger people in Chicago, Illinois, 2005–2011. Public Health Rep. 2017; 132(1):48–55.
https://doi.org/10.1177/0033354916679988 PMID: 28005480
19. Wilton L, Herbst JH, Coury-Doniger P, Painter TM, English G, Alvarez ME, et al. Efficacy of an HIV/STI
prevention intervention for black men who have sex with men: findings from the Many Men, Many
Voices (3MV) project. AIDS Behav. 2009; 13(3):532–544. https://doi.org/10.1007/s10461-009-9529-y
PMID: 19267264
20. Workowski KA, Akinyemi D, Bachmann L, Burstein G, Cohen S, Gardella C, et al. Sexually transmitted
diseases treatment guidelines, 2015. 2015. MMWR Recomm. Rep., 64(33):924.
21. Cooley LA, Oster AM, Rose CE, Wejnert C, Le BC, Paz-Bailey G, et al. Increases in HIV testing among
men who have sex with men—National HIV Behavioral Surveillance System, 20 U.S. metropolitan sta-
tistical areas, 2008 and 2011. PLoS One, 9(9), e104162. https://doi.org/10.1371/journal.pone.0104162
PMID: 25180514
22. Mannheimer SB, Wang L, Wilton L, Van Tieu H, del Rio C, Buchbinder S, et al. Infrequent HIV Testing
and Late HIV Diagnosis Are Common Among a Cohort of Black Men Who Have Sex With Men in 6 US
Cities. J Acquir Immune Defic Syndr. 2014; 67(4):438–445.
23. Lelutiu-Weinberger C, Golub SA. Enhancing PrEP access for Black and Latino men who have sex with
men. J Acquir Immune Defic Syndr. 2016; 73(5):547–555.
24. Peng P, Su S, Fairley CK, Chu M, Jiang S, Zhuang X, et al. A global estimate of the acceptability of pre-
exposure prophylaxis for HIV among men who have sex with men: A systematic review and meta-analy-
sis. AIDS Behav. 2017 Feb 7. https://doi.org/10.1007/s10461-017-1675-z PMID: 28176168
25. Smith DK, Herbst JH, Rose CE. Estimating protective effects of method adherence with combinations
of preexposure prophylaxis and condom use among African American men who have sex with men.
Sex Transm Dis. 2015; 42(2):88–92. https://doi.org/10.1097/OLQ.0000000000000238 PMID:
25585067
26. Branson BM, Handsfield HH, Lampe MA, Janssen RS, Taylor AW, Lyss SB, et al. Revised recommen-
dations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR
Recomm Rep. 2006; 55(RR-14):1–17. PMID: 16988643
27. Clark H, Babu AS, Wiewel EW, Opoku J, Crepaz N. Diagnosed HIV infection in transgender adults and
adolescents: Results from the National HIV Surveillance System, 2009–2014. AIDS Behav. 2017.
21:2774–2783. https://doi.org/10.1007/s10461-016-1656-7 PMID: 28035497
28. Lemos D, Hosek SG, Bell M. Reconciling reality with fantasy: Exploration of the sociocultural factors
influencing HIV transmission among Black young men who have sex with men (BYMSM) within the
House Ball community: A Chicago study. J Gay Lesbian Soc Serv. 2015; 27(1):64–85. https://doi.org/
10.1080/10538720.2015.988837 PMID: 26034382
29. Sanchez T, Finlayson T, Murrill C. Risk behaviors and psychosocial stressors in the New York City
house ball community: A comparision of men and transgender women who have sex with men. AIDS
Behav. 2010; 14(2):351–358. https://doi.org/10.1007/s10461-009-9610-6 PMID: 19763812
30. Adam PCG, de Wit JBF. A concise overview of barriers and facilitators to HIV testing. Directions for
future research and interventions. Utrecht, the Netherlands: Institute for Prevention and Social
Research. https://www.researchgate.net/profile/Philippe_Adam2/publication/237126867_A_concise_
overview_of_barriers_and_facilitators_of_HIV_testing/links/0c96052669bc047015000000.pdf?origin=
publication_detail. Accessed 27 Feb 2017.
31. Garofalo R, Deleon J, Osmer E, Doll M, Harper GW. Overlooked, misunderstood and at-risk: Exploring
the lives and HIV risk of ethnic minority male-to-female transgender youth. J Adolesc Heallth. 2006; 38
(3):230–236.
32. Levy ME, Wilton L, Phillips G 2nd, Glick SN, Kuo I, Brewer RA, et al. Understanding structural barriers
to accessing HIV testing and prevention services among Black men who have sex with men (BMSM) in
the United States. AIDS Behav. 2014; 18(5):972–996. https://doi.org/10.1007/s10461-014-0719-x
PMID: 24531769
33. Mayer KH, Garofalo R, Makadon HJ. Promoting the successful development of sexual and gender
minority youths. Am J Public Health. 2014; 104(6):976–981. https://doi.org/10.2105/AJPH.2014.
301876 PMID: 24825194
34. St Lawrence JS, Kelly JA, Dickson-Gomez J, Owczarzak J, Amirkhanian YA, Sitzler C. Attitudes toward
HIV voluntary counseling and testing (VCT) among African American men who have sex with men: Con-
cerns underlying relunctance to test. AIDS Educ Prev. 2015; 27(3):195–211. https://doi.org/10.1521/
aeap.2015.27.3.195 PMID: 26010312
YBMSM and HIV testing
PLOS ONE | https://doi.org/10.1371/journal.pone.0192936 February 20, 2018 16 / 18
35. Garofalo R. Tipping points in caring for the gender-nonconforming child and adolescent. Pediatr Ann.
2014; 43(6):227–229. https://doi.org/10.3928/00904481-20140522-06 PMID: 24972418
36. Graham LF, Crissman HP, Tocco J, Hughes L, Snow RC, Padilla MB. Interpersonal relationships and
social support in transitioning narratives of Black transgender women in Detroit. Int J Transgend. 2014;
15(2):100–113.
37. Mashburn AJ, Peterson JL, Bakeman R, Miller RL, Clark LF, The Community Intervention Trial for
Youth (CITY). Influences on HIV testing among African-American men who have sex with men and the
moderating effect of the geographic setting. J Community Psychol. 2004; 32(1):45–60.
38. Scott HM, Pollack L, Rebchook GM, Huebner DM, Peterson J, Kegeles SM et al. Peer social support is
associsated with recent HIV testing among young black men who have sex with men. AIDS Behav.
2014; 18(5):913–20. https://doi.org/10.1007/s10461-013-0608-8 PMID: 24065436
39. Arnold EA, Bailey MM. Constructing home and family: How the ballroom community supports African
American GLBTQ youth in the face of HIV/AIDS. J Gay Lesbian Soc Serv. 2009; 21(2–3):171–188.
https://doi.org/10.1080/10538720902772006 PMID: 23136464
40. Frye V, Wilton L, Hirshfield S, Chiasson MA, Usher D, Lucy D. “Just because it’s out there, people aren’t
going to use it.” HIV self-testing among young, Black MSM, and transgender women. AIDS Patient
Care STDs. 2015; 29(11):617–624. https://doi.org/10.1089/apc.2015.0100 PMID: 26376029
41. Hightow-Weidman LB, Muessig KE, Pike EC, LeGrand S, Baltierra N, Rucker AJ, et al. HealthMpower-
ment.org: Building community through a mobile-optimized, online health promotion intervention. Health
Educ Behav. 2015; 42(4):493–499. https://doi.org/10.1177/1090198114562043 PMID: 25588932
42. Golub SA, Gamarel KE. The impact of anticipated HIV stigma on delays in HIV testing behaviors: find-
ings from a community-based sample of men who have sex with men and transgender women in New
York City. AIDS Patient.Care STDS. 2013; 27(11):621–627. https://doi.org/10.1089/apc.2013.0245
PMID: 24138486
43. Santos GM, Beck J, Wilson PA, Hebert P, Makofane K, Pyun T, et al. Homophobia as a barrier to HIV
prevention service access for young men who have sex with men. J Acquir Immune Defic Syndr. 2013;
63(5):e167–e170.
44. Stekler J, Wood RW, Swenson PD, Golden M. Negative rapid HIV antibody testing during early HIV
infection. Ann Intern Med. 2007; 147(2):147–148.
45. Stephenson R, Sullivan PS, Salazar LF, Gratzer B, Allen S, Seelbach E. Attitudes towards couples-
based HIV testing among MSM in three US cities. AIDS Behav. 2011; 15 Suppl 1:S80–S87. https://doi.
org/10.1007/s10461-011-9893-2 PMID: 21336607
46. Hussen SA, Stephenson R, del Rio C, Wilton L, Wallace J, Wheeler D, et al. HIV testing patterns among
black men who have sex with men: a qualitative typology. PLOS ONE. 2013 Sep 19; 8(9):e75382.
https://doi.org/10.1371/journal.pone.0075382 PMID: 24069408
47. Patton MQ. Qualitative research and evalution methods. 4th ed. Thousand Oaks, CA: Sage Publica-
tions, Inc.; 2014.
48. Corbin J, Straus A. (1998). The basics of qualitative research: Techniques and procedures for develop-
ing grounded theory. Thousand Oaks, CA: Sage Publications, Inc.; 2014.
49. McCree DH, Millett G, Baytop C, Royal S, Ellen J, Halkitis PN, et al. Lessons learned from use of social
network strategy in HIV testing programs targeting African Amerian men who have sex with men. Am J
Public Health. 2013; 03(10):1851–1866.
50. Nemoto T, Cruz TM, Iwanmoto M, Sakata M. A tale of two cities: Access to care and services among
African-American transgender women in Oakland and San Francisco. LGBT Health. 2015; 2(3):235–
242. https://doi.org/10.1089/lgbt.2014.0046 PMID: 26788672
51. Pavie J, Rachline A, Loze B, Loze B, Niedbalski L, Laforgerie E, et al. (2010). Sensitivity of five rapid
HIV tests on oral fluid or finger-stick whole blood: a real-time comparison in a healthcare setting. PLoS
One. 2010; 5(7):e11581. https://doi.org/10.1371/journal.pone.0011581 PMID: 20657834
52. Centers for Disease Control and Prevention. False-positive oral fluid rapid HIV tests—New York City,
2005–2008. MMWR Morb Mortal Wkly Rep. 2008; 57(24):660–665. PMID: 18566566
53. Klarkowski D, O’Brien DP, Shanks L, Sing KP. Causes of false-positive HIV rapid diagnostic test results.
Expert Rev Anti Infect Ther. 2014; 12(1):49–62. https://doi.org/10.1586/14787210.2014.866516 PMID:
24404993
54. Metsch LR, Feaster DJ, Gooden L, Matheson T, Mandler RN, Haynes L, et al. Implementing rapid HIV
testing with or without risk-reduction counseling in drug treatment centers: Results of a randomized trial.
Am J Public Health. 2012; 102(6):1160–1167. https://doi.org/10.2105/AJPH.2011.300460 PMID:
22515871
YBMSM and HIV testing
PLOS ONE | https://doi.org/10.1371/journal.pone.0192936 February 20, 2018 17 / 18
55. Metsch LR, Feaster DJ, Gooden L, Schackman BR, Matheson T, Das M, et al. Effect of risk-reduction
counseling with rapid HIV testing on risk of acquiring sexually transmitted infections: the AWARE ran-
domized clinical trial. JAMA. 2013; 310(16):1701–1710.
56. Eaton LA, Driffin DD, Kegler C, Smith H, Conway-Washington C, White D, et al. The role of stigma and
medical mistrust in the routine health care engagement of black men who have sex with men. Am J Pub-
lic Health. 2015; 105(2):e75–e82. https://doi.org/10.2105/AJPH.2014.302322 PMID: 25521875
57. Irvin R, Wilton L, Scott H, Beauchamp G, Wang L, Betancourt J, et al. A study of perceived racial dis-
crimination in Black men who have sex with men (MSM) and its association with healthcare utilization
and HIV testing. AIDS & Behavior. 2014; 18:1272–1278.
58. Morris E, Topete P, Rasberry CN, Lesesne CA, Kroupa E, Carner L. School-based HIV/STD testing
behaviors and motivations among Black and Hispanic teen MSM: Results from a formative evaluation.
J Sch Health. 2016; 86(12):888–897. https://doi.org/10.1111/josh.12457 PMID: 27866390
59. Halkitis PN, Kupprat SA, McCree DH, Simons SM, Jabouin R, Hampton MC, et al. Evaluation of the rel-
ative effectiveness of three HIV testing strategies targeting African American men who have sex with
men (MSM) in New York City. Ann Behav Med. 2011; 42(3):361–369. https://doi.org/10.1007/s12160-
011-9299-4 PMID: 21818527
YBMSM and HIV testing
PLOS ONE | https://doi.org/10.1371/journal.pone.0192936 February 20, 2018 18 / 18
